223 related articles for article (PubMed ID: 24448395)
1. GATA2 as a potential metastasis-driving gene in prostate cancer.
Chiang YT; Wang K; Fazli L; Qi RZ; Gleave ME; Collins CC; Gout PW; Wang Y
Oncotarget; 2014 Jan; 5(2):451-61. PubMed ID: 24448395
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of GATA2 in prostate cancer by a clinically available small molecule.
Kaochar S; Rusin A; Foley C; Rajapakshe K; Robertson M; Skapura D; Mason C; Berman De Ruiz K; Tyryshkin AM; Deng J; Shin JN; Fiskus W; Dong J; Huang S; Navone NM; Davis CM; Ehli EA; Coarfa C; Mitsiades N
Endocr Relat Cancer; 2021 Nov; 29(1):15-31. PubMed ID: 34636746
[TBL] [Abstract][Full Text] [Related]
3. Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer.
Qu S; Ci X; Xue H; Dong X; Hao J; Lin D; Clermont PL; Wu R; Collins CC; Gout PW; Wang Y
Br J Cancer; 2018 Mar; 118(6):802-812. PubMed ID: 29381682
[TBL] [Abstract][Full Text] [Related]
4. MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT.
Shen T; Wang W; Zhou W; Coleman I; Cai Q; Dong B; Ittmann MM; Creighton CJ; Bian Y; Meng Y; Rowley DR; Nelson PS; Moore DD; Yang F
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33586682
[TBL] [Abstract][Full Text] [Related]
5. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer.
Büscheck F; Zub M; Heumann A; Hube-Magg C; Simon R; Lang DS; Höflmayer D; Neubauer E; Jacobsen F; Hinsch A; Luebke AM; Tsourlakis MC; Sauter G; Huland H; Graefen M; Haese A; Heinzer H; Schlomm T; Clauditz TS; Burandt E; Wilczak W; Steurer S; Minner S
Tumour Biol; 2019 Jul; 41(7):1010428318824815. PubMed ID: 31296150
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2.
Das R; Gregory PA; Fernandes RC; Denis I; Wang Q; Townley SL; Zhao SG; Hanson AR; Pickering MA; Armstrong HK; Lokman NA; Ebrahimie E; Davicioni E; Jenkins RB; Karnes RJ; Ross AE; Den RB; Klein EA; Chi KN; Ramshaw HS; Williams ED; Zoubeidi A; Goodall GJ; Feng FY; Butler LM; Tilley WD; Selth LA
Cancer Res; 2017 Feb; 77(4):1021-1034. PubMed ID: 28011622
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression.
Saraon P; Cretu D; Musrap N; Karagiannis GS; Batruch I; Drabovich AP; van der Kwast T; Mizokami A; Morrissey C; Jarvi K; Diamandis EP
Mol Cell Proteomics; 2013 Jun; 12(6):1589-601. PubMed ID: 23443136
[TBL] [Abstract][Full Text] [Related]
8. The role of GATA2 in lethal prostate cancer aggressiveness.
Rodriguez-Bravo V; Carceles-Cordon M; Hoshida Y; Cordon-Cardo C; Galsky MD; Domingo-Domenech J
Nat Rev Urol; 2017 Jan; 14(1):38-48. PubMed ID: 27872477
[TBL] [Abstract][Full Text] [Related]
9. Transient receptor potential melastatin 4 channel contributes to migration of androgen-insensitive prostate cancer cells.
Holzmann C; Kappel S; Kilch T; Jochum MM; Urban SK; Jung V; Stöckle M; Rother K; Greiner M; Peinelt C
Oncotarget; 2015 Dec; 6(39):41783-93. PubMed ID: 26496025
[TBL] [Abstract][Full Text] [Related]
10. Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression.
Shajari N; Davudian S; Kazemi T; Mansoori B; Salehi S; Khaze Shahgoli V; Shanehbandi D; Mohammadi A; Duijf PHG; Baradaran B
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1495-1504. PubMed ID: 28889753
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner.
Tam KJ; Dalal K; Hsing M; Cheng CW; Khosravi S; Yenki P; Tse C; Peacock JW; Sharma A; Chiang YT; Wang Y; Cherkasov A; Rennie PS; Gleave ME; Ong CJ
Oncotarget; 2017 Feb; 8(6):9617-9633. PubMed ID: 28038451
[TBL] [Abstract][Full Text] [Related]
12. Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer.
Wu D; Sunkel B; Chen Z; Liu X; Ye Z; Li Q; Grenade C; Ke J; Zhang C; Chen H; Nephew KP; Huang TH; Liu Z; Jin VX; Wang Q
Nucleic Acids Res; 2014 Apr; 42(6):3607-22. PubMed ID: 24423874
[TBL] [Abstract][Full Text] [Related]
13. The Pioneering Role of GATA2 in Androgen Receptor Variant Regulation Is Controlled by Bromodomain and Extraterminal Proteins in Castrate-Resistant Prostate Cancer.
Chaytor L; Simcock M; Nakjang S; Heath R; Walker L; Robson C; Jones D; Gaughan L
Mol Cancer Res; 2019 Jun; 17(6):1264-1278. PubMed ID: 30833300
[TBL] [Abstract][Full Text] [Related]
14. CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2.
Seo WY; Jeong BC; Yu EJ; Kim HJ; Kim SH; Lim JE; Kwon GY; Lee HM; Kim JH
Nucleic Acids Res; 2013 Oct; 41(18):8526-36. PubMed ID: 23887938
[TBL] [Abstract][Full Text] [Related]
15. Taxane resistance in prostate cancer mediated by AR-independent GATA2 regulation of IGF2.
Plymate SR; Bhatt RS; Balk SP
Cancer Cell; 2015 Feb; 27(2):158-9. PubMed ID: 25670076
[TBL] [Abstract][Full Text] [Related]
16. Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors.
Hankey W; Chen Z; Wang Q
Cancer Res; 2020 Jun; 80(12):2427-2436. PubMed ID: 32094298
[TBL] [Abstract][Full Text] [Related]
17. TMEM45B is a novel predictive biomarker for prostate cancer progression and metastasis.
Luo F; Yang K; Wang YZ; Lin D
Neoplasma; 2018 Sep; 65(5):815-821. PubMed ID: 30249106
[TBL] [Abstract][Full Text] [Related]
18. GATA2 co-opts TGFβ1/SMAD4 oncogenic signaling and inherited variants at 6q22 to modulate prostate cancer progression.
Yang X; Zhang Q; Li S; Devarajan R; Luo B; Tan Z; Wang Z; Giannareas N; Wenta T; Ma W; Li Y; Yang Y; Manninen A; Wu S; Wei GH
J Exp Clin Cancer Res; 2023 Aug; 42(1):198. PubMed ID: 37550764
[TBL] [Abstract][Full Text] [Related]
19. Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression.
Yan J; Erdem H; Li R; Cai Y; Ayala G; Ittmann M; Yu-Lee LY; Tsai SY; Tsai MJ
Cancer Res; 2008 Jul; 68(13):5460-8. PubMed ID: 18593949
[TBL] [Abstract][Full Text] [Related]
20. GATA2-Mediated Transcriptional Activation of Notch3 Promotes Pancreatic Cancer Liver Metastasis.
Lin H; Hu P; Zhang H; Deng Y; Yang Z; Zhang L
Mol Cells; 2022 May; 45(5):329-342. PubMed ID: 35534193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]